Measurement of brain natriuretic peptide in plasma samples and cardiac tissue extracts by means of an immunoradiometric assay method

Citation
S. Del Ry et al., Measurement of brain natriuretic peptide in plasma samples and cardiac tissue extracts by means of an immunoradiometric assay method, SC J CL INV, 60(2), 2000, pp. 81-90
Citations number
38
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research General Topics
Journal title
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
ISSN journal
00365513 → ACNP
Volume
60
Issue
2
Year of publication
2000
Pages
81 - 90
Database
ISI
SICI code
0036-5513(200004)60:2<81:MOBNPI>2.0.ZU;2-E
Abstract
We evaluated the analytical characteristics and clinical usefulness of a co mmercial immunoradiometric assay (IRMA) kit for brain natriuretic peptide ( BNP). Mean (+/-SD) plasma BNP concentrations measured in 129 normal subject s were 2.9+/-2.7 pmol/l (median 2.2 pmol/l; range 0.1-12.4 pmol/l). The mea n (+/-SD) value observed in healthy men (2.1+/-2.0 pmol/l, n=49) was signif icantly (p=0.0009) different to that found in women (3.4+/-2.9 pmol/l, n=80 ). A positive relationship (R=0.214, p=0.0174) was found between BNP values and age; In 65 patients with cardiac diseases, BNP levels increased with t he progression of clinical severity of disease; patients with more severe d isease [NYHA functional class III-IV, mean (+/-SD) BNP=254+/-408 pmol/l, n= 22] showed significantly (p<0.0001) increased values compared to patients w ith mild symptoms of disease (NYHA functional class I-II, mean (+/-SD) BNP= 19.6+/-17.2 pmol/l, n=43). Furthermore, in 32 patients with chronic renal f ailure, greatly increased (p<0.0001) BNP Values were found both before (mea n+/-SD=88.1+/-111.1 pmol/l) and after haemodialysis (mean +/- SD=65.6+/-76. 7 pmol/l), with a significant reduction after haemodialysis (p=0.0004) comp ared to pre-haemodialysis. The mean (+/-SD) BNP value found in atrial extra cts collected during aorto-coronary bypass operations in 15 patients was 14 .5+/-51.9 pmol/g of cardiac tissue. Moreover, the mean (+/-SD) tissue level s of BNP in 7 heart transplant recipients were 128.4+/-117.2 pmol/g of card iac tissue in atrium, 68.4+/-76.7 pmol/g in ventricle, and 10.9+/-8.5 pmol/ g in interventricular septum. Finally, BNP values found in cardiac tissues of two subjects collected at autopsy were considerably lower (on average 1/ 1000) than those observed in cardiac tissues of patients with cardiac disea ses. The IRMA method for BNP determination evaluated in this study showed a good degree of sensitivity, precision and practicability. Therefore, this method should be a reliable tool for the measurement of plasma BNP levels f or both experimental studies and routine assay.